GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-141 Cr | ₹-146 Cr | ₹-134 Cr | ₹-113 Cr | ₹-103 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-141 Cr |
| Mar2024 | ₹-146 Cr |
| Mar2023 | ₹-134 Cr |
| Mar2022 | ₹-113 Cr |
| Mar2021 | ₹-103 Cr |
How is Deferred Tax Assets / Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-141 Cr | Negative | |
| Mar2024 | ₹-146 Cr | Negative | |
| Mar2023 | ₹-134 Cr | Negative | |
| Mar2022 | ₹-113 Cr | Negative | |
| Mar2021 | ₹-103 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹39,463.4 Cr | -2.9% | -9.8% | 13.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -2.9% |
-9.8% |
13.1% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses